Accès gratuit
Biologie Aujourd'hui
Volume 208, Numéro 1, 2014
Page(s) 55 - 68
Section La vitamine D, une hormone stéroïde méconnue
Publié en ligne 23 juin 2014
  • Adami S., Giannini S., Bianchi L., Sinigaglia L., Di Munno O., Fiore C.E., Minisola S., Rossini M., Vitamin D status and response to treatment in post-menopausal osteoporosis. Osteoporos Int, 2009, 20, 239–244. [CrossRef] [PubMed] [Google Scholar]
  • Adams J., Hewison M., Update in vitamin D. J Clin Endocrinol Metab, 2010, 95, 471–478. [CrossRef] [PubMed] [Google Scholar]
  • Aloia J., Talwar S., Pollack S., Feuerman M., Yeh J.K., Optimal vitamin D status and serum parathyroid hormone concentrations in African American women. Am J Clin Nutr, 2006, 84, 602–609. [PubMed] [Google Scholar]
  • Armas L.A.G., Hollis B.W., Heaney R.P., Vitamin D2 is much less effective than vitamin D3 in humans. J Clin Endocrinol Metab, 2004, 89, 5387–5391. [CrossRef] [PubMed] [Google Scholar]
  • Arnson Y., Amital H., Shoenfeld Y. Vitamin D and autoimmunity: new aetiological and therapeutic considerations. Ann Rheum Dis, 2007, 66, 1137–1142. [CrossRef] [PubMed] [Google Scholar]
  • Autier P, Gandini S., Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. Arch Intern Med, 2007, 167, 1730–1737. [CrossRef] [PubMed] [Google Scholar]
  • Benhamou C.L., Souberbielle J.C., Cortet B., Fardellone P., Gauvain J.B., Thomas T. La vitamine D chez l’adulte: recommandations du GRIO. Presse Med, 2011, 40, 7–16. [Google Scholar]
  • Bienaimé F., Girard D., Anglicheau D., Canaud G., Souberbielle J.C., Kreis H., Noël L.H., Friedlander G., Elie C., Legendre C., Prié D., Vitamin D, renal function and outcome in renal transplantation. J Am Soc Nephrol, 2013, 24, 831–841. [CrossRef] [PubMed] [Google Scholar]
  • Bischoff-Ferrari H., Giovanucci E., Willett W., Dietrich T., Dawson-Hughes B., Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple outcomes. Am J Clin Nutr, 2006, 84, 18–28. [PubMed] [Google Scholar]
  • Bischoff-Ferrari H., Dawson-Hughes B., Staehelin H.B., Orav J.E., Stuck A.E., Theiler R., Wong J.B., Egli A., Kiel D.P., Henschkowski J., Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials. BMJ, 2009a, 339, b3692. [Google Scholar]
  • Bischoff-Ferrari H., Willett W., Wong J., Stuck A.E., Staehelin H.B., Orav E.J., Thoma A., Kiel D.P., Henschkowski J., Prevention of nonvertebral fractures with oral vitamin D and dose dependency. Arch Int Med, 2009b, 169, 551–561. [Google Scholar]
  • Bjelakovic C., Gluud L.L., Nikolova D., Whitfield K., Wetterslev J., Simonetti R.G., Bjelakovic M., Gluud C., Vitamin D supplementation for prevention of mortality in adults (Review). Cochrane Database Syst Rev, 2014, Issue 1, DOI: 10.1002/14651858.CD007470. [Google Scholar]
  • Bodnar L., Catov J., Simham H., Holick M.F., Powers R.W., Roberts J.M., Maternal vitamin D deficiency increases the risk of preeclampsia. J Clin Endocrinol Metab, 2007, 92, 3517–3522. [CrossRef] [PubMed] [Google Scholar]
  • Bouillon R., Van Schoor N.M., Gielen E., Boonen S., Mathieu C., Vanderschueren D., Lips P., Optimal vitamin D status: a critical analysis on the basis of evidence-based medicine. J Clin Endocrinol Metab, 2013, 98, E1283–1304. [CrossRef] [PubMed] [Google Scholar]
  • Camargo C., Ganmaa D., Frazier L., Kirchberg F.F., Stuart J.J., Kleinman K., Sumberzul N., Rich-Edwards J.W., Randomized trial of vitamin D supplementation and risk of acute respiratory infection in Mongolia. Pediatrics, 2012, 130, 561–567. [CrossRef] [Google Scholar]
  • Carmel A., Shieh A., Bang H., Blockman R., The 25(OH)D level to maintain a favourable bisphosphonate response is >33 ng/mL. Osteoporos Int, 2012, 23, 2479–2487. [CrossRef] [PubMed] [Google Scholar]
  • Cashman K., Fitzgerald A., Kiely M., Seamans K.M. A systematic review and meta-regression analysis of the vitamin D intake-serum 25-hydroxyvitamin D relationship to inform European recommendations. Br J Nutr, 2011, 106, 1638–1648. [CrossRef] [PubMed] [Google Scholar]
  • Courbebaisse M., Thervet E., Souberbielle J.C., Zuber J., Eladari D., Martinez F., Mamzer-Bruneel M.F., Urena P., Legendre C., Friedlander G., Prié D., Effects of vitamin D supplementation on the calcium-phosphate balance in renal transplant patients. Kidney Int, 2009, 75, 646–651. [CrossRef] [PubMed] [Google Scholar]
  • Dawson-Hughes B., Heaney R., Holick M., Lips P., Meunier P.J., Vieth R., Estimates of optimal vitamin D status. Osteoporos Int, 2005, 16, 713–716. [CrossRef] [PubMed] [Google Scholar]
  • Dawson-Hughes B., Mithal A., Bonjour J.P., Boonen S., Burckhardt P., Fuleihan G.E., Josse R.G., Lips P., Morales-Torres J., Yoshimura N., IOF position statements: vitamin D recommendations for older adults. Osteoporos Int, 2010, 21, 1151–1154. [CrossRef] [PubMed] [Google Scholar]
  • Dong Y., Stallmann-Jorgensen I.S., Pollock N.K., Harris R.A., Keeton D., Huang Y., Li K., Bassali R., Guo D.H., Thomas J., Pierce G.L., White J., Holick M.F., Zhu H., A 16-week randomized clinical trial of 2000 international units daily vitamin D3 supplementation in black youth: 25-hydroxy vitamin D, adiposity, and arterial stiffness. J Clin Endocrinol Metab, 2010, 95, 4584–4591. [CrossRef] [PubMed] [Google Scholar]
  • Eastell R., Arnold A., Brandi M.L., Brown E.M., D’Amour P., Hanley D.A., Rao D.S., Rubin M.R., Goltzman D., Silverberg S.J., Marx S.J., Peacock M., Mosekilde L., Bouillon R, Lewiecki EM., Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J Clin Endocrinol Metab, 2009, 94, 340–350. [CrossRef] [PubMed] [Google Scholar]
  • Feskanich D, Ma J, Fuchs C.S., Kirkner G.J., Hankinson S.E., Hollis B.W., Giovannucci E.L., Plasma vitamin D metabolites and risk of colorectal cancer in women. Cancer Epidemiol Biomarkers Prev, 2004, 13, 1502–1508. [PubMed] [Google Scholar]
  • Garland C.F., Gorham E.D., Mohr S.B., Grant W.B., Giovannucci E.L., Lipkin M., Newmark H., Holick M.F., Garland F.C., Vitamin D and prevention of breast cancer: pooled analysis. J Steroid Biochem Mol Biol, 2007, 103, 708–711. [CrossRef] [PubMed] [Google Scholar]
  • Grey A., Lucas J., Horne A., Gamble G., Davidson J.S., Reid I.R., Vitamin D repletion in patients with primary hyperparathyroidism and coexistent vitamin D insufficiency. J Clin Endocrinol Metab, 2005, 90, 2122–2126. [CrossRef] [PubMed] [Google Scholar]
  • Hanley D., Cranney A., Jones G., Whiting S.J., Leslie W.D., Cole D.E., Atkinson S.A., Josse R.G., Feldman S., Kline G.A., Rosen C., Vitamin D in adult health and disease: a review and guideline statement from Osteoporosis Canada. CMAJ, 2010, 182, E610–E618. [CrossRef] [PubMed] [Google Scholar]
  • Hathcock J., Shao A., Vieth R., Heaney R., Risk assessment for vitamin D. Am J Clin Nutr, 2007, 85, 6–18 [PubMed] [Google Scholar]
  • Heaney R., Holick M., Why the IOM recommendations for vitamin D are deficient. J Bone Miner Res, 2011, 26, 455–457. [CrossRef] [PubMed] [Google Scholar]
  • Holick M., Resurrection of vitamin D deficiency and rickets. J Clin Invest, 2006, 116, 2062–2072 [CrossRef] [PubMed] [Google Scholar]
  • Holick M., Vitamin D deficiency. N Engl J Med, 2007, 357, 266–281. [CrossRef] [PubMed] [Google Scholar]
  • Holick M., Chen T., Lu Z., Sauter E., Vitamin D and skin physiology : a D-lightful story. J Bone Miner Res, 2007, 2 (suppl 2), V28–V33. [CrossRef] [Google Scholar]
  • Holick M., Biancuzzo R.M., Chen T.C., Klein E.K., Young A., Bibuld D., Reitz R., Salameh W., Ameri A., Tannenbaum A.D., Vitamin D2 is as effective as vitamin D3 in maintaining circulating concentrations of 25-hydroxyvitamin D. J Clin Endocrinol Metab, 2008, 93, 677–681. [CrossRef] [PubMed] [Google Scholar]
  • Holick M., Binkley N., Bischoff-Ferrari H., Gordon C.M., Hanley D.A., Heaney R.P., Murad M.H., Weaver C.M., Evaluation, treatment and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab, 2011, 96, 1911–1930. [CrossRef] [PubMed] [Google Scholar]
  • Ish-Shalom S., Segal E., Salganik T., Raz B., Bromberg I.L., Vieth R., Comparison of daily, weekly, and monthly vitamin D3 in ethanol dosing protocols for two months in elderly hip fracture patients. J Clin Endocrinol Metab, 2008, 93, 3430–3435. [CrossRef] [PubMed] [Google Scholar]
  • Jean G., Souberbielle J.C., Chazot C., Strategy for vitamin D supplementation. Monthly cholecalciferol administration in hemodialysis patients : a simple and efficient strategy for vitamin D supplementation. Nephrol Dial Transplant, 2009, 24, 3799–3805. [CrossRef] [PubMed] [Google Scholar]
  • KDIGO. Clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int, 2009, 79, S1–S130. [Google Scholar]
  • Kim M.J., Frankel A., Donaldson M., Darch S.J., Pusey C.D., Hill P.D., Mayr M., Tam F.W., Oral cholecalciferol decreases albuminuria and urinary TGF-β1 in patients with type 2 diabetic nephropathy on established rennin-angiotensin-aldosterone system inhibition. Kidney Int, 2011, 80, 851–860. [CrossRef] [PubMed] [Google Scholar]
  • Lappe J.M., Travers-Gustafson D., Davies K.M., Recker R.R., Heaney R.P., Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr, 2007, 85, 1586–1591. [PubMed] [Google Scholar]
  • Lieben L., Masuyama R., Torrekens S., Van Looveren R., Schrooten J., Baatsen P., Lafage-Proust M.H., Dresselaers T., Feng J.Q., Bonewald L.F., Meyer M.B., Pike J.W., Bouillon R., Carmeliet G., Normocalcemia is maintained in mice under conditions of calcium malabsorption by vitamin D-induced inhibition of bone mineralization. J Clin Invest, 2012, 122, 1803–1815. [CrossRef] [PubMed] [Google Scholar]
  • Liu P.T., Stenger S., Li H., Wenzel L., Tan B.H., Krutzik S.R., Ochoa M.T., Schauber J., Wu K., Meinken C., Kamen D.L., Wagner M., Bals R., Steinmeyer A., Zügel U., Gallo R.L., Eisenberg D., Hewison M., Hollis B.W., Adams J.S., Bloom B.R., Modlin R.L., Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science, 2006, 311, 1770–1773. [CrossRef] [PubMed] [Google Scholar]
  • Looker A., Serum 25-hydroxyvitamin D and risk of major osteoporotic fractures in older US adults. J Bone Miner Res, 2013, 28, 997–1006. [CrossRef] [PubMed] [Google Scholar]
  • Lowe H., McMahon D.J., Rubin M., Bilezikian J.P., Silverberg S.J., Normocalcemic primary hyperparathyroidism : further characterization of a new clinical phenotype. J Clin Endocrinol Metab, 2007, 92, 3001–3005. [CrossRef] [PubMed] [Google Scholar]
  • Luxwolda M., Kuiperst R., Kema I., Dijck-Brouwer D.A., Muskiet F.A., Traditionnally living populations in East Africa have a mean serum 25-hydroxyvitamin D concentration of 115 nmol/L. Brit J Nutr, 2012, 108, 1557–1561. [CrossRef] [PubMed] [Google Scholar]
  • Mithal A., Wahl D.A., Bonjour J.P., Dawson-Hughes B., Eisman J.A., El-Hajj Fuleihan G., Josse R.G., Lips P., Morales-Torres J., Global vitamin D status and determinants of hypovitaminosis D. Osteoporos Int, 2009, 11, 1807–1820. [CrossRef] [Google Scholar]
  • Mitri J., Dawson-Hughes B., Hu F., Pittas A.G., Effects of vitamin D and calcium supplementation on pancreatic beta cell function, insulin sensitivity, and glycemia in adults at high risk of diabetes: the calcium and vitamin D for diabetes mellitus (CaDDM) randomized controlled trial. Am J Clin Nutr, 2011, 94, 486–494. [CrossRef] [PubMed] [Google Scholar]
  • Nemere I., Schwartz Z., Pedroso H., Sylvia V.L., Dean D.D., Boyan B.D., Identification of a membrane receptor for 1,25-dihydroxyvitamin D3 which mediates rapid activation of protein kinase C. J Bone Miner Res, 1998, 13, 1353–1359. [CrossRef] [PubMed] [Google Scholar]
  • Nimer A., Mouch A., Vitamin D improves viral response in hepatitis C genotype 2-3 naïve patients. World J Gastroenterol, 2012, 18, 800–805. [CrossRef] [PubMed] [Google Scholar]
  • Okazaki R., Sugimoto T., Kaji H., Fujii Y., Shiraki M., Inoue D., Endo I., Okano T., Hirota T., Kurahashi I., Matsumoto T., Vitamin D insufficiency defined by serum 25-hydroxyvitamin D and parathyroid hormone before and after oral vitamin D3 supplementation load in Japanese patients. J Bone Miner Metab, 2011, 29, 103–110. [CrossRef] [PubMed] [Google Scholar]
  • Omenn G.S., Goodman G.E., Thomquist M.D., Balmes J., Cullen M.R., Glass A., Keogh J.P., Meyskens F.L., Valanis B., Williams J.H., Barnhart S., Hammar S., Effects of a combination of β-carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med, 1996, 334, 1150–1155. [CrossRef] [PubMed] [Google Scholar]
  • Perez-Lopez F., Brincat M., Erel T., Trémollieres F., Gambacciani M., Lambrinoudaki I., Moen M.H., Schenck-Gustafsson K., Vujovic S., Rozenberg S., Rees M., EMAS position statement : vitamin D and postmenopausal health. Maturitas, 2012, 71, 83–88. [CrossRef] [PubMed] [Google Scholar]
  • Pilz S., Tomaschitz A., Ritz E., Vitamin D status and arterial hypertension: a systematic review. Nat Rev Cardiol, 2009, 6, 621–630. [CrossRef] [PubMed] [Google Scholar]
  • Pilz S., Iodice S., Zittermann A., Grant W.B., Gandini S., Vitamin D status and mortality risk in CKD: a meta-analysis of prospective studies. Am J Kidney Dis, 2011, 58, 374–382. [PubMed] [Google Scholar]
  • Poel Y.H.M., Hummel P., Lips P., Stam F., van der Ploeg T., Simsek S., Vitamin D and gestational diabetes : a systematic review and meta-analysis. Eur J Intern Med, 2012, 23, 465–469. [CrossRef] [PubMed] [Google Scholar]
  • Priemel M., von Domarus C., Klatte T.O., Kessler S., Schlie J., Meier S., Proksch N., Pastor F., Netter C., Streichert T., Püschel K., Amling M., Bone mineralization defects and vitamin D deficiency: histomorphometric analysis of iliac crest bone biopsies and circulating 25-hydroxyvitamin D in 675 patients. J Bone Miner Res, 2010, 25, 305–312. [CrossRef] [PubMed] [Google Scholar]
  • Rejnmark L., Avenell A., Masud T., Anderson F., Meyer H.E., Sanders K.M., Salovaara K., Cooper C., Smith H.E., Jacobs E.T., Torgerson D., Jackson R.D., Manson J.E., Brixen K., Mosekilde L., Robbins J.A., Francis R.M., Abrahamsen B., Vitamin D with calcium reduces mortality: patient level pooled analysis of 70 528 patients from eight major vitamin D trials. J Clin Endocrinol Metab, 2012, 97, 2670–2681. [CrossRef] [PubMed] [Google Scholar]
  • Rolighed L., Rejnmark L., Sikjaer T., Heickendorff L., Vestergaard P., Mosekilde L., Christiansen P. Vitamin D treatment in primary hyperparathyroidism: a randomized placebo controlled trial. J Clin Endocrinol Metab, 2014; doi: 10.1210/jc.2013-3978. [Google Scholar]
  • Ross C., Manson J.E., Abrams S., Aloia J.F., Brannon P.M., Clinton S.K., Durazo-Arvizu R.A., Gallagher J.C., Gallo R.L., Jones G., Kovacs C.S., Mayne S.T., Rosen C.J., Shapses S.A., The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine : what clinicians need to know. J Clin Endocrinol Metab, 2011, 96, 53–58. [CrossRef] [PubMed] [Google Scholar]
  • Sanders K.M., Stuart A.L., Williamson E.J., Simpson J.A., Kotowicz M.A., Young D., Nicholson G.C., Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial. JAMA, 2010, 303, 1815–1822. [CrossRef] [PubMed] [Google Scholar]
  • Schleithoff S.S., Zittermann A., Tenderich G., Berthold H.K., Stehle P., Koerfer R., Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial. Am J Clin Nutr, 2006, 83, 754–759. [PubMed] [Google Scholar]
  • Schlingmann K.P., Pirruccello J.P., Do R., Irwin A., Goos C., John U., Misselwitz J., Klaus G., Kuwertz-Bröking E., Fehrenbach H., Wingen A.M., Güran T., Hoenderop J.G., Bindels R.J., Prosser D.E., Jones G., Konrad M., Mutations in CYP24A1 and idiopathic infantile hypercalcemia. N Engl J Med, 2011, 365, 410–421. [CrossRef] [PubMed] [Google Scholar]
  • Smith H., Anderson F., Raphael H., Maslin P., Crozier S., Cooper C., Effect of annual intramuscular vitamin D on fracture risk in elderly men and women-a population-based, randomized, double-blind, placebo-controlled trial. Rheumatology (Oxford), 2007, 46, 1852–1857. [CrossRef] [PubMed] [Google Scholar]
  • Souberbielle J.C., Maury E., Friedlander G., Cormier C., Vitamin D and primary hyperparathyroidism (PHPT). J Steroid Biochem Mol Biol, 2010, 121, 199–203. [CrossRef] [PubMed] [Google Scholar]
  • Stolzenberg-Solomon R.Z., Jacobs E.J., Arslan A.A., Qi D., Patel A.V., Helzlsouer K.J., Weinstein S.J., McCullough M.L., Purdue M.P., Shu X.O., Snyder K., Virtamo J., Wilkins L.R., Yu K., Zeleniuch-Jacquotte A., Zheng W., Albanes D., Cai Q., Harvey C., Hayes R., Clipp S., Horst R.L., Irish L., Koenig K., Le Marchand L., Kolonel L.N., Circulating 25-hydroxyviatmin D and risk of pancreatic cancer: cohort consortium vitamin D pooling project of rarer cancers. Am J Epidemiol, 2010, 172, 81–93. [CrossRef] [PubMed] [Google Scholar]
  • Tuohimaa P., Tenkanen L., Ahonen M., Lumme S., Jellum E., Hallmans G., Stattin P., Harvei S., Hakulinen T., Luostarinen T., Dillner J., Lehtinen M., Hakama M., Both high and low levels of blood vitamin D are associated with a higher prostate cancer risk: a longitudinal, nested case-control study in the Nordic countries. Int J Cancer, 2004, 108, 104–10. [CrossRef] [PubMed] [Google Scholar]
  • Urashima M., Segawa T., Okazaki M., Kurihara M., Wada Y., Ida H., Randomized trial of vitamin D supplementation to prevent seasonal influenza A in schoolchildren. Am J Clin Nutr, 2010, 91, 1255–1260. [CrossRef] [PubMed] [Google Scholar]
  • Vernay M., Sponga M., Salanave B., Oléko A., Deschamps V., Malon A., Castetbon K., Statut en vitamine D de la population adulte en France : l’étude nationale nutrition santé (ENNS, 2006-2007). BEH 24 avril 2012 : 189–194. [Google Scholar]
  • Vieth R. Why the optimal requirement for vitamin D3 is probably much higher than what is officially recommended for adults. J Steroid Biochem Mol Biol, 2004, 89, 575–579. [CrossRef] [PubMed] [Google Scholar]
  • Wepner F., Scheuer R., Schuetz-Wieser B., Machacek P., Pieler-Bruha E., Cross H.S., Hahne J., Friedrich M., Effects of vitamin D on patients with fibromyalgia syndrome: a randomized placebo-controlled trial. Pain, 2014, 155, 261–268. [CrossRef] [PubMed] [Google Scholar]
  • Witham M.D., Nadir M.A., Struthers A.D., Effect of vitamin D on blood pressure a systematic review and meta-analysis. J Hypertens, 2009, 27, 1948–1954. [CrossRef] [PubMed] [Google Scholar]
  • Zheng Y., Zhu J., Zhou M., Cui L., Yao W., Liu Y., Meta-analysis of long-term vitamin D supplementation on overall mortality. Plos One, 2013, 12, e82109. [CrossRef] [Google Scholar]
  • Zitterman A., Iodice S., Pilz S., Grant W.B., Bagnardi V., Gandini S., Vitamin D deficiency and mortality risk in the general population: a meta-analysis of prospective cohort studies. Am J Clin Nutr, 2012, 95, 91–100. [CrossRef] [PubMed] [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.